Related Experiment Videos
Carpal tunnel syndrome associated with interleukin-2 therapy
V K Puduvalli1, A Sella, S G Austin
1Department of Neurology, University of Texas Medical School, Houston, USA.
Cancer
|March 15, 1996
Summary
Interleukin-2 (IL-2) cancer therapy can cause carpal tunnel syndrome. Symptoms typically resolve upon discontinuing IL-2 treatment, suggesting a drug-induced inflammatory process.
Area of Science:
- Oncology
- Neurology
- Immunology
Background:
- Interleukin-2 (IL-2) is widely used for cancer treatment.
- IL-2 therapy is associated with various neurological side effects.
- Carpal tunnel syndrome (CTS) is a potential side effect of IL-2 treatment.